A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance
- 1 August 1991
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 64 (2) , 361-364
- https://doi.org/10.1038/bjc.1991.307
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Addition of verapamil and tamoxifen to the initial chemotherapy of small cell lung cancer a phase I/II studyCancer, 1990
- Effects of cyclosporin a and verapamil on the intracellular daunorubicin accumulation in chinese hamster ovary cells with increasing levels of drug‐resistanceInternational Journal of Cancer, 1989
- A rapid and sensitive flow cytometric method for the detection of multidrug‐resistant cellsCytometry, 1989
- Effect of cyclosporin A on daunorubicin accumulation in multidrug-resistant P388 leukemia cells measured by real-time flow cytometryCancer Chemotherapy and Pharmacology, 1989
- Expression of Multidrug Resistance Gene in Human CancersJNCI Journal of the National Cancer Institute, 1989
- Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell lineBritish Journal of Cancer, 1987
- Multiple-Drug Resistance in Human CancerNew England Journal of Medicine, 1987
- Human Multidrug-Resistant Cell Lines: Increased mdr 1 Expression Can Precede Gene AmplificationScience, 1986
- Clinical relevance of verapamil plasma levels in stable angina pectorisThe American Journal of Cardiology, 1982
- Chemotherapy of Gastrointestinal CancerNew England Journal of Medicine, 1978